A meta-analysis and systematic review of the first Trop-2-targeting antibody–drug conjugate (sacituzumab govitecan) in treating metastatic breast cancer - Jue Wang; Shengyou Lin; Jialin Zhang; Jingyang Su (European Journal of Clinical Pharmacology, 2025)